Our new paper is out @NatureComms

Published by sahinozgur on

With the title of “Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer”.

https://www.nature.com/articles/s41467-023-42736-y?utm_source=rct_congratemailt&utm_medium=email&utm_campaign=oa_20231102&utm_content=10.1038/s41467-023-42736-y
Categories: News

0 Comments

Leave a Reply

Avatar placeholder

Your email address will not be published. Required fields are marked *

Related Posts

News

See the latest news about our lab!

“Hollings team marks milestone in progress toward investigational new drug for triple-negative breast cancer” https://hollingscancercenter.musc.edu/news/archive/2024/07/22/lox-inhibitor-for-triple-negative-breast-cancer

News

New paper alert!

A highly potent bi-thiazole inhibitor of LOX rewires collagen architecture and enhances chemoresponse in triple-negative breast cancer https://www.sciencedirect.com/science/article/pii/S2451945624002733?via%3Dihub

News

Presenting three posters at AACR Annual Meeting 2024!

We participated in the AACR conference with three distinct poster presentations.